Spyre Therapeutics, Inc 10-K for FY2020
Spyre Therapeutics, Inc. (SYRE)
10-K
2021-03-18
For: 2020-12-31
View Original
Added on
April 10, 2026
About this 10-K
Spyre Therapeutics, Inc filed this 10-K on March 18, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $0 a year earlier
- Net loss
- $80.89M
- compared with a net loss of $78.25M a year earlier